Qure.ai (founded 2016) uses artificial intelligence to make high-quality healthcare more accessible and affordable worldwide. We build validated medical-imaging AI solutions that help clinicians detect and manage conditions earlier, improve care pathways, and enable scalable public‑health screening programs.

We develop AI products for medical imaging and care coordination, including chest X‑ray reporting (qXR), TB screening and program management (qTrack), lung nodule management, stroke & TBI detection (qER), MSK X‑ray reporting, and heart‑failure support. Our solutions are designed to integrate with existing imaging systems and workflows across hospitals, screening programs, and life‑sciences partners.

Qure.ai is deployed globally across 100+ countries and thousands of sites, with millions of lives impacted. Our solutions have been evaluated by WHO and have received regulatory clearances (FDA, CE) and adhere to privacy standards (HIPAA, GDPR). We partner with healthcare providers, global health organizations, and industry leaders such as AstraZeneca, Medtronic and Philips to scale early detection and timely intervention for TB, lung cancer, stroke and other conditions.